Laura L. Johnson - 01 Jul 2022 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role
Director
Signature
/s/ Anthony Scott Praill, attorney-in-fact for Laura L. Johnson
Issuer symbol
HURA
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 16:05:57 UTC
Previous filing
14 Jan 2022
Next filing
24 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +100,000 $0.000000 100,000 01 Jul 2022 Common Stock 100,000 $0.2550 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022.